28 January 2011 in The Journal of Physiology
27 October 2014 in The Journal of Physiology
1 April 2010 in Arteriosclerosis, Thrombosis, and Vascular Biology
Objective—
Circulating progenitor cells (CPC) have emerged as potential mediators of vascular repair. In experimental models, CPC mobilization is critically dependent on nitric oxide (NO). South Asian ethnicity is associated with reduced CPC. We assessed CPC mobilization in response to exercise in Asian men and examined the role of NO in CPC mobilization per se.
Methods and Results—
In 15 healthy, white European men and 15 matched South Asian men, CPC mobilization was assessed during moderate-intensity exercise. Brachial artery flow-mediated vasodilatation was used to assess NO bioavailability. To determine the role of NO in CPC mobilization, identical exercise studies were performed during intravenous separate infusions of saline, the NO synthase inhibitor l -NMMA, and norepinephrine. Flow-mediated vasodilatation (5.8%±0.4% vs 7.9%±0.5%; P =0.002) and CPC mobilization (CD34 + /KDR + 53.2% vs 85.4%; P =0.001; CD133 + /CD34 + /KDR + 48.4% vs 73.9%; P =0.05; and CD34 + /CD45 − 49.3% vs 78.4; P =0.006) was blunted in the South Asian group. CPC mobilization correlated with flow-mediated vasodilatation and l -NMMA significantly reduced exercise-induced CPC mobilization (CD34 + /KDR + −3.3% vs 68.4%; CD133 + /CD34 + /KDR + 0.7% vs 71.4%; and CD34 + /CD45 − −30.5% vs 77.8%; all P <0.001).
Conclusion—
In humans, NO is critical for CPC mobilization in response to exercise. Reduced NO bioavailability may contribute to imbalance between vascular damage and repair mechanisms in South Asian men.
15 September 2013 in Journal of Applied Physiology
The integration of skeletal muscle substrate depletion, metabolite accumulation, and fatigue during large muscle-mass exercise is not well understood. Measurement of intramuscular energy store degradation and metabolite accumulation is confounded by muscle heterogeneity. Therefore, to characterize regional metabolic distribution in the locomotor muscles, we combined31P magnetic resonance spectroscopy, chemical shift imaging, and T2-weighted imaging with pulmonary oxygen uptake during bilateral knee-extension exercise to intolerance. Six men completed incremental tests for the following: 1) unlocalized31P magnetic resonance spectroscopy; and 2) spatial determination of31P metabolism and activation. The relationship of pulmonary oxygen uptake to whole quadriceps phosphocreatine concentration ([PCr]) was inversely linear, and three of four knee-extensor muscles showed activation as assessed by change in T2. The largest changes in [PCr], [inorganic phosphate] ([Pi]) and pH occurred in rectus femoris, but no voxel (72 cm3) showed complete PCr depletion at exercise cessation. The most metabolically active voxel reached 11 ± 9 mM [PCr] (resting, 29 ± 1 mM), 23 ± 11 mM [Pi] (resting, 7 ± 1 mM), and a pH of 6.64 ± 0.29 (resting, 7.08 ± 0.03). However, the distribution of31P metabolites and pH varied widely between voxels, and the intervoxel coefficient of variation increased between rest (∼10%) and exercise intolerance (∼30–60%). Therefore, the limit of tolerance was attained with wide heterogeneity in substrate depletion and fatigue-related metabolite accumulation, with extreme metabolic perturbation isolated to only a small volume of active muscle (<5%). Regional intramuscular disturbances are thus likely an important requisite for exercise intolerance. How these signals integrate to limit muscle power production, while regional “recruitable muscle” energy stores are presumably still available, remains uncertain.
1 February 2009 in Appetite
1 August 2012 in Journal of Applied Physiology
Cardiopulmonary exercise testing for peak oxygen uptake (V̇o2peak) can evaluate prognosis in chronic heart failure (CHF) patients, with the peak respiratory exchange ratio (RERpeak) commonly used to confirm maximal effort and maximal oxygen uptake (V̇o2max). We determined the precision of RERpeak in confirming V̇o2max, and whether a novel ramp-incremental (RI) step-exercise (SE) (RISE) test could better determine V̇o2max in CHF. Male CHF patients ( n = 24; NYHA class I–III) performed a symptom-limited RISE-95 cycle ergometer test in the format: RI (4–18 W/min; ∼10 min); 5 min recovery (10 W); SE (95% peak RI work rate). Patients ( n = 18) then performed RISE-95 tests using slow (3–8 W/min; ∼15 min) and fast (10–30 W/min; ∼6 min) ramp rates. Pulmonary gas exchange was measured breath-by-breath. V̇o2peak was compared within patients by unpaired t-test of the highest 12 breaths during RI and SE phases to confirm V̇o2max and its 95% confidence limits (CI95). RERpeak was significantly influenced by ramp rate (fast, medium, slow: 1.21 ± 0.1 vs. 1.15 ± 0.1 vs. 1.09 ± 0.1; P = 0.001), unlike V̇o2peak (mean n = 18; 14.4 ± 2.6 ml·kg−1·min−1; P = 0.476). Group V̇o2peak was similar between RI and SE ( n = 24; 14.5 ± 3.0 vs. 14.7 ± 3.1 ml·kg−1·min−1; P = 0.407); however, within-subject comparisons confirmed V̇o2max in only 14 of 24 patients (CI95 for V̇o2max estimation averaged 1.4 ± 0.8 ml·kg−1·min−1). The RERpeak in CHF was significantly influenced by ramp rate, suggesting its use to determine maximal effort and V̇o2max be abandoned. In contrast, the RISE-95 test had high precision for V̇o2max confirmation with patient-specific CI95 (without secondary criteria), and showed that V̇o2max is commonly underestimated in CHF. The RISE-95 test was well tolerated by CHF patients, supporting its use for V̇o2max confirmation.